Urbanavičiūtė, R.; Skauminas, K.; Skiriutė, D.
The Evaluation of AREG, MMP-2, CHI3L1, GFAP, and OPN Serum Combined Value in Astrocytic Glioma Patients’ Diagnosis and Prognosis. Brain Sci. 2020, 10, 872.
https://doi.org/10.3390/brainsci10110872
AMA Style
Urbanavičiūtė R, Skauminas K, Skiriutė D.
The Evaluation of AREG, MMP-2, CHI3L1, GFAP, and OPN Serum Combined Value in Astrocytic Glioma Patients’ Diagnosis and Prognosis. Brain Sciences. 2020; 10(11):872.
https://doi.org/10.3390/brainsci10110872
Chicago/Turabian Style
Urbanavičiūtė, Rūta, Kęstutis Skauminas, and Daina Skiriutė.
2020. "The Evaluation of AREG, MMP-2, CHI3L1, GFAP, and OPN Serum Combined Value in Astrocytic Glioma Patients’ Diagnosis and Prognosis" Brain Sciences 10, no. 11: 872.
https://doi.org/10.3390/brainsci10110872
APA Style
Urbanavičiūtė, R., Skauminas, K., & Skiriutė, D.
(2020). The Evaluation of AREG, MMP-2, CHI3L1, GFAP, and OPN Serum Combined Value in Astrocytic Glioma Patients’ Diagnosis and Prognosis. Brain Sciences, 10(11), 872.
https://doi.org/10.3390/brainsci10110872